Livforsakringsbolaget Skandia Omsesidigt purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 24,231 shares of the company’s stock, valued at approximately $9,445,000.
A number of other hedge funds have also recently bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $5,069,974,000. Norges Bank bought a new position in HCA Healthcare during the 4th quarter valued at $1,262,513,000. Legal & General Group Plc acquired a new position in HCA Healthcare during the 2nd quarter worth $410,992,000. Jupiter Topco LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $371,138,000. Finally, Life Cycle Investment Partners Ltd acquired a new position in HCA Healthcare in the fourth quarter worth about $374,037,000. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Trading Down 0.4%
Shares of NYSE HCA opened at $417.57 on Friday. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The company has a market cap of $90.40 billion, a PE ratio of 13.98, a P/E/G ratio of 1.46 and a beta of 1.10. The stock has a 50 day simple moving average of $401.08 and a 200-day simple moving average of $441.46.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s payout ratio is 10.45%.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Barclays decreased their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Oppenheimer dropped their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Morgan Stanley lowered their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. JPMorgan Chase & Co. decreased their target price on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday, August 20th. Finally, Wells Fargo & Company increased their price target on HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $462.64.
Check Out Our Latest Research Report on HCA
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Recommended Stories
- Five stocks we like better than HCA Healthcare
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
